Opioid use disorder: who works on it

One card per institution. Pick a target or a country to narrow the list.

• All targets
• GLP-1 1

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

No running funded project names this disease yet.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Suspended

  Measuring the Effects of Neurostimulation on Risky and Ambiguous Decision-Making Capacity in People With and Without Substance Use Disorder

  NCT06577454· National Institute on Drug Abuse (NIDA)· Updated 13 Nov 2026

  “Study on hold - participant recruitment suspended due to staffing limitations.”Registry text, quoted unchanged. Source

• Withdrawn

  Low-Intensity Focused Ultrasound and the Complex Patient

  NCT06297200· Virginia Polytechnic Institute and State University· Updated 9 Nov 2026

  “Unable to recruit any eligible participants.”Registry text, quoted unchanged. Source

• Suspended

  Neuroplasticity in Maternal Opioid Use Disorder (OUD)

  NCT05495984· Yale University· Updated 14 Sept 2026

  “PI in transition, assessing feasibility of study continuation”Registry text, quoted unchanged. Source

• Withdrawn

  Sublingual Buprenorphine Through Telemedicine vs In-Person Care as Usual

  NCT05339256· New York State Psychiatric Institute· Updated 8 Sept 2026

  “Due to a federally mandated, institution-wide pause in research activities under the institution's Federal Wide Assurance (FWA) that occurred during the timeline for this study, recruitment was never initiated and no participants were enrolled.”Registry text, quoted unchanged. Source

• Terminated

  Using AI and Peer Coaching to Address Racial Disparities Among People Who Use Opioids

  NCT06569667· Friends Research Institute, Inc.· Updated 8 Sept 2026

  “Loss of sponsor funding”Registry text, quoted unchanged. Source

• Terminated

  A Study to Test Whether BI 1356225 Improves Impulsive Behavior in People With Opioid Use Disorder Who Are Taking Buprenorphine

  NCT06628622· Boehringer Ingelheim· Updated 31 Jul 2026

  “Sponsor decision”Registry text, quoted unchanged. Source

• Terminated

  Anchoring Sequential Intermittent Long Acting Antimicrobials With Medication for Opioid Use Disorder (MOUD) for Invasive Infections Related to Opioid Use

  NCT05521880· University of Maryland, Baltimore· Updated 24 Jul 2026

  “The study was not able to enroll adequate participants within predetermined timelines”Registry text, quoted unchanged. Source

• Terminated

  Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics

  NCT06624137· Yale University· Updated 9 Jul 2026

  “Funding ended.”Registry text, quoted unchanged. Source

• Withdrawn

  Transition From Acute to Chronic Opioid Use and Chronic Pain

  NCT07211399· Jacques E. Chelly· Updated 30 Jun 2026

  “Study did not receive funding.”Registry text, quoted unchanged. Source

• Terminated

  Implementation of STTR Strategies Among People Who Inject Drugs in Malaysia

  NCT03987282· Yale University· Updated 29 Jun 2026

  “lack of eligible participants”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• Measuring the Effects of Neurostimulation on Risky and Ambiguous Decision-Making Capacity in People With and Without Substance Use Disorder

  NCT06577454· National Institute on Drug Abuse (NIDA)· Source

• Digital Treatment for Chronic Pain and Addiction in Veterans With Opioid Use Disorder Receiving Buprenorphine

  NCT07361432· VA Office of Research and Development· Source

• Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)

  NCT04464980· NYU Langone Health· Source

• E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder

  NCT05722561· NYU Langone Health· Source

• NOTRE: Optimizing Long-Acting Pre-Exposure Prophylaxis and Medications for Opioid Use Disorder Interventions in Carceral Settings

  NCT06854029· Duke University· Source

• EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy

  NCT04921787· Gavin Bart· Source

• Prescribe to Prevent HIV: A Hybrid Trial Helping Addiction Clinics Prevent HIV & Infections Through Safer Drug Use Support

  NCT07073924· University of Pittsburgh· Source

• EXHIT ENTRE Comparative Effectiveness Trial

  NCT04345718· Gavin Bart· Source

• Targeting Treatment-Resistant OUD With Ketamine-Assisted Mindfulness Oriented Recovery Enhancement

  NCT07369089· University of California, San Diego· Source

• Evaluating Pain Control Strategies in Postpartum Patients on Opioid Use Disorder Medications.

  NCT06617949· Medical College of Wisconsin· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 1
• Organoids 1
• Mendelian Randomization Analysis 3
• Gene Expression Profiling 5
• Proteomics 2
• Metabolomics 1
• Mass Spectrometry 1
• Positron-Emission Tomography 2
• Magnetic Resonance Imaging 15
• Machine Learning 19
• Deep Learning 3
• Cohort Studies 72
• Genome-Wide Association Study 6

See which targets of this disease your abstract mentions, and go to the people working on them.